HOME >> BIOLOGY >> NEWS
Vaccine protects against fatal West Nile complication

A vaccine already approved in the United States to prevent a related disease protects experimental animals and may also protect people from the most serious complication associated with West Nile virus infection, say researchers from the University of Texas Medical Branch at Galveston (UTMB).

They report their findings today at the 50th Annual Meeting of the American Society of Tropical Medicine and Hygiene in Atlanta.

Dr. Robert Tesh, a professor in the Center for Tropical Diseases at UTMB and his colleagues tested two vaccines for Japanese encephalitis (JE) for their its ability to protect hamsters from the fatal encephalitis (inflammation of the brain) that is associated with West Nile viral infection.

The JE virus is a flavivirus, a member of the same viral family as the West Nile virus, dengue virus and St. Louis encephalitis virus.

"It looks like the West Nile virus is spreading throughout the Western Hemisphere and it will probably go all the way through the tropics and down to Argentina says Tesh.

In the United States we haven't had much exposure to flaviviruses; but we wanted to see what could happen when the West Nile virus reached an area like Central America where people have already had exposure to other flaviviruses, either through infection or vaccination.

Previous studies in India have suggested that prior infection with the JE virus will protect monkeys from fatal West Nile infections. In this study Tesh and his colleagues first inoculated hamsters with one of three flavivirus vaccines: a live-attenuated JE vaccine currently used on millions of people in China, a killed-virus JE vaccine currently approved for use in the United States and a yellow fever vaccine.

"If we infect hamsters with the New York strain of West Nile virus about half will die of encephalitis if they have not had a previous flavivirus infection," says Tesh. But in the case of the JE-vaccinated hamsters "none of them
'"/>

Contact: Jim Sliwa
jsliwa@asmusa.org
202-942-9297
American Society for Microbiology
14-Nov-2001


Page: 1 2

Related biology news :

1. Hope Clinic of Emory Vaccine Center receives CDC contract
2. Vaccines against foodborne disease on horizon
3. GenVec, U.S. NMRC, and PATHs Malaria Vaccine Initiative partner to expand malaria vaccine efforts
4. Vaccine technique shows potential against common form of lung cancer
5. Fighting fire with fire? Vaccine based on chimp virus shows promise against HIV
6. Emory Vaccine Research Center study identifies specific gene required for long-term immunity
7. Vaccine prevents stroke in rats
8. Vaccine puts blood-sucking ticks off their food
9. Dr. Robert C. Gallo to Collaborate with Visiting Israeli Scientist on Promising HIV Vaccine Research at Marylands Institute of Human Virology
10. Vaccine controls AIDS in monkeys, researchers report in Science
11. Vaccine put into tomatoes shows promise fighting virus in lab tests

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/2/2017)... Summary This report provides all the information ... partnering interests and activities since 2010. Download the ... Deals and Alliance since 2010 report provides an in-depth ... world,s leading life sciences companies. On demand ... of the most up to date deal and company ...
(Date:3/2/2017)... MELBOURNE, Australia , March 2, 2017 ... Therapeutics Ltd (ASX: CYP), has signed an agreement ... researchers from the Monash Biomedicine Discovery Institute and Department ... , to conduct a further preclinical study to support ... the treatment of asthma.  Asthma is ...
(Date:2/28/2017)... 28, 2017   Acuant , a leading provider ... significant enhancements to new and core technologies building upon ... include mobile and desktop Acuant FRM TM facial ... a real time manual review of identity documents by ... the fastest and most accurate capture software to streamline ...
Breaking Biology News(10 mins):
(Date:3/24/2017)... YORK , March 24, 2017 ... ended the trading session at 5,817.69, down 0.07%; the ... at 20,656.58; and the S&P 500 closed at 2,345.96, ... as 4 sectors closed in green, 4 sectors finished ... day. This Friday, Stock-Callers.com has initiated reports coverage on ...
(Date:3/23/2017)... Mar 23, 2017 Research and Markets ... Markets" report to their offering. ... The Global Market for ... in 2016 at a CAGR of 8.9%, ... non-energetic bioproducts into seven major product segments: bio-derived chemicals, biofuels, ...
(Date:3/23/2017)... Branford, CT (PRWEB) , ... March 23, 2017 ... ... Counsel, LLC, was recently selected by the Connecticut Technology Council (CTC) as a ... honored at CTC’s thirteenth annual Women of Innovation Awards Dinner. , The dinner ...
(Date:3/23/2017)... In today,s pre-market research, Stock-Callers.com ... Biotech industry: Sangamo Therapeutics Inc. (NASDAQ: SGMO), Eyegate Pharmaceuticals ... and Regulus Therapeutics Inc. (NASDAQ: RGLS ). ... its rating on Pharmaceuticals/Biotechnology to "Overweight" from "Market Weight." Learn more ... ...
Breaking Biology Technology:
Cached News: